Nab-Paclitaxel相关论文
Enhancing nab-paclitaxel response by targeted inhibition of FGF/PDGF/VEGF signaling pathways in prec
...
Efficacy and toxicity comparison of nab-paclitaxel plus S-1 and nab-paclitaxel plus gemcitabine as f
...
...
Nab-paclitaxel(abraxane)-based chemotherapy to treat elderly patients with advanced non-small-cell l
Background:The purpose of this study is to evaluate the clinical efficacy and safety of abraxane-based chemotherapy with......
The most widely used chemotherapeutic combinations in locally advanced (LA) or metastatic pancreatic ductal adenocarcino......
This report describes a patient with metastatic epithelioid hemangioendothelioma treated with bevacizumab and nanopartic......
化疗在局部晚期/晚期头颈部肿瘤的治疗中发挥重要作用,对提高肿瘤局部控制率、延缓肿瘤进展、减少远处转移及延长患者生存时间有重......
Pancreatic cancer is the fourth leading cause of cancerrelated death worldwide.Extensive research has yielded advances i......
Pancreatic cancer is the fourth leading cause of cancerrelated death worldwide.Extensive research has yielded advances i......
Background: Locally advanced or metastatic pancreatic cancer patients have a poor prognosis with median survival less th......
Background: Locally advanced or metastatic pancreatic cancer patients have a poor prognosis with median survival less th......
Impressive Objective Response to Nab-Paclitaxel plus Trastuzumab as Fifth Line Therapy in an Elderly
Background: Agent targeting HER-2 pathway plus chemotherapy has represented a major progress in the management of patien......
Impressive Objective Response to Nab-Paclitaxel plus Trastuzumab as Fifth Line Therapy in an Elderly
Background: Agent targeting HER-2 pathway plus chemotherapy has represented a major progress in the management of patien......
Multiline treatment of advanced squamous cell carcinoma of the lung: A case report and review of the
BACKGROUND Squamous cell carcinoma (SCC) is one the most common subtypes of non-small cell lung cancer, yet the treatmen......
Adjuvant nab-paclitaxel plus gemcitabine vs gemcitabine alone for resected pancreatic ductal adenoca
BACKGROUND Nab-paclitaxel plus gemcitabine(AG)has resulted in higher tumor response and survival rates for metastatic or......
紫杉烷类药物是被批准用于临床治疗肿瘤的重要新型药物,主要用于转移性乳腺癌、卵巢癌和非小细胞肺癌的治疗。然而,目前市售的溶剂......
期刊
